Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to IV Darbepoetin Alfa in Hemodialysis
NCT00116701Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2005
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Amgen. Started May 2005; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00116701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116701.